Financhill
Sell
35

HPQ Quote, Financials, Valuation and Earnings

Last price:
$22.30
Seasonality move :
3.74%
Day range:
$22.27 - $22.90
52-week range:
$21.21 - $35.28
Dividend yield:
5.24%
P/E ratio:
8.40x
P/S ratio:
0.38x
P/B ratio:
--
Volume:
9.7M
Avg. volume:
13.2M
1-year change:
-31.72%
Market cap:
$20.5B
Revenue:
$55.3B
EPS (TTM):
$2.65
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $63.2B $62B $53.5B $53.2B $55.3B
Revenue Growth (YoY) 11.88% -1.92% -13.8% -0.61% 4.09%
 
Cost of Revenues $50.2B $50.8B $42.4B $41.9B $44.1B
Gross Profit $13.1B $11.3B $11.1B $11.2B $11.3B
Gross Profit Margin 20.66% 18.15% 20.72% 21.14% 20.34%
 
R&D Expenses $1.8B $1.7B $1.6B $1.6B $1.6B
Selling, General & Admin $5.7B $5.3B $5.4B $5.7B $5.8B
Other Inc / (Exp) $2.1B -$434M -$602M -$316M --
Operating Expenses $7.6B $6.9B $6.9B $7.3B $7.4B
Operating Income $5.5B $4.3B $4.2B $3.9B $3.8B
 
Net Interest Expenses $254M $359M $684M $607M $555M
EBT. Incl. Unusual Items $7.6B $4.3B $2.9B $3.3B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1B $1.2B -$326M $504M $139M
Net Income to Company $6.5B $3.1B $3.3B $2.8B $2.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.5B $3.1B $3.3B $2.8B $2.5B
 
Basic EPS (Cont. Ops) $5.41 $3.02 $3.29 $2.83 $2.67
Diluted EPS (Cont. Ops) $5.36 $2.98 $3.26 $2.81 $2.65
Weighted Average Basic Share $1.2B $1B $992M $979M $946M
Weighted Average Diluted Share $1.2B $1.1B $1B $989M $953M
 
EBITDA $6.3B $5.1B $5B $4.8B $4.7B
EBIT $5.5B $4.3B $4.2B $3.9B $3.8B
 
Revenue (Reported) $63.2B $62B $53.5B $53.2B $55.3B
Operating Income (Reported) $5.5B $4.3B $4.2B $3.9B $3.8B
Operating Income (Adjusted) $5.5B $4.3B $4.2B $3.9B $3.8B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $16.6B $14.4B $13.8B $14B $14.7B
Revenue Growth (YoY) 8.01% -13.48% -4.06% 1.36% 5.14%
 
Cost of Revenues $13.5B $12.1B $10.9B $11.1B $11.7B
Gross Profit $3.1B $2.3B $2.9B $2.9B $3B
Gross Profit Margin 18.84% 15.87% 21.13% 20.75% 20.35%
 
R&D Expenses $445M $442M $411M $392M $398M
Selling, General & Admin $1.5B $1.2B $1.3B $1.4B $1.4B
Other Inc / (Exp) $2.3B -$268M -$152M -$115M --
Operating Expenses $1.9B $1.6B $1.7B $1.8B $1.8B
Operating Income $1.2B $656M $1.2B $1.1B $1.2B
 
Net Interest Expenses $61M $130M $156M $147M $125M
EBT. Incl. Unusual Items $3.6B $556M $852M $862M $834M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $454M $629M -$122M -$44M $39M
Net Income to Company $3.1B -$23M $974M $906M $795M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.1B -$73M $974M $906M $795M
 
Basic EPS (Cont. Ops) $2.75 -$0.07 $0.98 $0.94 $0.85
Diluted EPS (Cont. Ops) $2.71 -$0.07 $0.97 $0.93 $0.84
Weighted Average Basic Share $1.1B $979.9M $994M $959M $938M
Weighted Average Diluted Share $1.1B $979.9M $1B $971M $948M
 
EBITDA $1.4B $855M $1.4B $1.3B $1.4B
EBIT $1.2B $656M $1.2B $1.1B $1.2B
 
Revenue (Reported) $16.6B $14.4B $13.8B $14B $14.7B
Operating Income (Reported) $1.2B $656M $1.2B $1.1B $1.2B
Operating Income (Adjusted) $1.2B $656M $1.2B $1.1B $1.2B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $63.7B $62B $53.5B $53.2B $55.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $50.3B $50.8B $42.4B $41.9B $44.2B
Gross Profit $13.4B $11.2B $11.1B $11.2B $11.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.9B $1.7B $1.6B $1.6B $1.6B
Selling, General & Admin $5.7B $5.3B $5.4B $5.7B $5.8B
Other Inc / (Exp) $2.1B -$447M -$602M -$309M --
Operating Expenses $7.6B $6.9B $6.9B $7.3B $7.4B
Operating Income $5.8B $4.3B $4.2B $3.9B $3.7B
 
Net Interest Expenses $256M $361M $648M $614M $555M
EBT. Incl. Unusual Items $7.5B $4.3B $2.9B $3.3B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1B $1.2B -$326M $504M $139M
Net Income to Company $6.5B $3.1B $3.3B $2.8B $2.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.5B $3.1B $3.3B $2.8B $2.5B
 
Basic EPS (Cont. Ops) $5.51 $2.98 $3.29 $2.84 $2.68
Diluted EPS (Cont. Ops) $5.44 $2.94 $3.26 $2.81 $2.65
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $6.6B $5.1B $5B $4.8B $4.7B
EBIT $5.8B $4.3B $4.2B $3.9B $3.7B
 
Revenue (Reported) $63.7B $62B $53.5B $53.2B $55.3B
Operating Income (Reported) $5.8B $4.3B $4.2B $3.9B $3.7B
Operating Income (Adjusted) $5.8B $4.3B $4.2B $3.9B $3.7B
Period Ending 2022-10-31 2023-10-31 2024-10-31 2025-10-31 2026-10-31
Revenue $62B $53.5B $53.2B $55.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $50.8B $42.4B $41.9B $44.2B --
Gross Profit $11.2B $11.1B $11.2B $11.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.7B $1.6B $1.6B $1.6B --
Selling, General & Admin $5.3B $5.4B $5.7B $5.8B --
Other Inc / (Exp) -$447M -$602M -$309M -$217M --
Operating Expenses $6.9B $6.9B $7.3B $7.4B --
Operating Income $4.3B $4.2B $3.9B $3.7B --
 
Net Interest Expenses $361M $648M $614M $555M --
EBT. Incl. Unusual Items $4.3B $2.9B $3.3B $2.7B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2B -$326M $504M $139M --
Net Income to Company $3.1B $3.3B $2.8B $2.5B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.1B $3.3B $2.8B $2.5B --
 
Basic EPS (Cont. Ops) $2.98 $3.29 $2.84 $2.68 --
Diluted EPS (Cont. Ops) $2.94 $3.26 $2.81 $2.65 --
Weighted Average Basic Share $4.1B $4B $3.9B $3.8B --
Weighted Average Diluted Share $4.2B $4B $4B $3.8B --
 
EBITDA $5.1B $5B $4.8B $4.7B --
EBIT $4.3B $4.2B $3.9B $3.7B --
 
Revenue (Reported) $62B $53.5B $53.2B $55.3B --
Operating Income (Reported) $4.3B $4.2B $3.9B $3.7B --
Operating Income (Adjusted) $4.3B $4.2B $3.9B $3.7B --
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Cash and Equivalents $4.3B $3.1B $3.2B $3.3B $3.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $5.5B $4.5B $4.2B $5.1B $5.7B
Inventory $7.9B $7.6B $6.9B $7.7B $8.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $2.1B $1.4B $1.5B --
Total Current Assets $22.1B $19.7B $18B $20.8B $22.5B
 
Property Plant And Equipment $3.7B $4B $4B $4.1B $4.2B
Long-Term Investments $128M $366M $181M $147M $164M
Goodwill $6.8B $8.5B $8.6B $8.6B --
Other Intangibles $784M $1.9B $1.6B $1.3B --
Other Long-Term Assets $697M $991M $853M $1.1B --
Total Assets $38.6B $38.5B $37B $39.9B $41.8B
 
Accounts Payable $16.1B $15.3B $14B $16.9B $18.1B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $672M $218M $230M $1.4B --
Current Portion Of Capital Lease Obligations $350M $405M $430M $443M --
Other Current Liabilities $7.1B $6.6B $6.1B $6B --
Total Current Liabilities $29.1B $26.2B $24.5B $28.7B $29.3B
 
Long-Term Debt $7.3B $11.7B $10.1B $9.1B $9.6B
Capital Leases -- -- -- -- --
Total Liabilities $40.2B $41.5B $38.1B $41.2B $42.1B
 
Common Stock $11M $10M $10M $9M $9M
Other Common Equity Adj -$245M $285M -$223M -$434M --
Common Equity -$1.6B -$3B -$1.1B -$1.3B -$346M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$1.6B -$3B -$1.1B -$1.3B -$346M
 
Total Liabilities and Equity $38.6B $38.5B $37B $39.9B $41.8B
Cash and Short Terms $4.3B $3.1B $3.2B $3.3B $3.7B
Total Debt $8B $11.8B $10.3B $10.4B $10.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Cash and Equivalents $4.3B $3.1B $3.2B $3.3B $3.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $5.5B $4.5B $4.2B $5.1B $5.7B
Inventory $7.9B $7.6B $6.9B $7.7B $8.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $2.1B $1.4B $1.5B --
Total Current Assets $22.1B $19.7B $18B $20.8B $22.5B
 
Property Plant And Equipment $3.7B $4B $4B $4.1B $4.2B
Long-Term Investments $128M $366M $181M $147M $164M
Goodwill $6.8B $8.5B $8.6B $8.6B --
Other Intangibles $784M $1.9B $1.6B $1.3B --
Other Long-Term Assets $697M $991M $853M $1.1B --
Total Assets $38.6B $38.5B $37B $39.9B $41.8B
 
Accounts Payable $16.1B $15.3B $14B $16.9B $18.1B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $672M $218M $230M $1.4B --
Current Portion Of Capital Lease Obligations $350M $405M $430M $443M --
Other Current Liabilities $7.1B $6.6B $6.1B $6B --
Total Current Liabilities $29.1B $26.2B $24.5B $28.7B $29.3B
 
Long-Term Debt $7.3B $11.7B $10.1B $9.1B $9.6B
Capital Leases -- -- -- -- --
Total Liabilities $40.2B $41.5B $38.1B $41.2B $42.1B
 
Common Stock $11M $10M $10M $9M $9M
Other Common Equity Adj -$245M $285M -$223M -$434M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$1.6B -$3B -$1.1B -$1.3B -$346M
 
Total Liabilities and Equity $38.6B $38.5B $37B $39.9B $41.8B
Cash and Short Terms $4.3B $3.1B $3.2B $3.3B $3.7B
Total Debt $8B $11.8B $10.3B $10.4B $10.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $6.5B $3.1B $3.3B $2.8B $2.5B
Depreciation & Amoritzation $785M $780M $850M $830M $824M
Stock-Based Compensation $330M $343M $438M $452M $522M
Change in Accounts Receivable -$105M $1.3B $278M -$929M -$524M
Change in Inventories -$2.2B $214M $668M -$852M -$828M
Cash From Operations $6.4B $4.5B $3.6B $3.7B $3.7B
 
Capital Expenditures $582M $791M $609M $592M $897M
Cash Acquisitions $854M $2.8B $7M $58M $116M
Cash From Investing -$1B -$3.5B -$590M -$646M -$1.2B
 
Dividends Paid (Ex Special Dividend) $938M $1B $1B $1.1B $1.1B
Special Dividend Paid
Long-Term Debt Issued $2.5B $4.2B $255M $380M --
Long-Term Debt Repaid -$1.2B -$1.1B -$1.7B -$213M --
Repurchase of Common Stock $6.2B $4.3B $100M $2.1B $850M
Other Financing Activities -- $279M -$203M -- --
Cash From Financing -$6B -$2.1B -$2.9B -$3.1B -$2.1B
 
Beginning Cash (CF) $4.3B $3.1B $3.2B $3.3B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$565M -$1.2B $87M $21M $460M
Ending Cash (CF) $3.7B $2B $3.3B $3.3B $4.2B
 
Levered Free Cash Flow $5.8B $3.7B $3B $3.2B $2.8B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $3.1B -$23M $974M $906M $795M
Depreciation & Amoritzation $200M $209M $212M $208M $116M
Stock-Based Compensation $70M $70M $85M $85M $90M
Change in Accounts Receivable -$608M $184M $98M -$482M -$578M
Change in Inventories $45M $784M $304M $101M -$157M
Cash From Operations $2.8B $1.9B $2B $1.6B $1.6B
 
Capital Expenditures $172M $144M $150M $153M $197M
Cash Acquisitions $272M $2.7B $2M $43M --
Cash From Investing -$400M -$2.9B -$20M -$132M -$64M
 
Dividends Paid (Ex Special Dividend) $219M $249M $260M $263M $270M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $447M $89M -$112M $114M --
Long-Term Debt Repaid -$53M -$952M -$56M -$60M --
Repurchase of Common Stock $1.8B $750M -- $900M $500M
Other Financing Activities -- $200M -- -- --
Cash From Financing -$1.6B -$1.3B -$441M -$1.1B -$721M
 
Beginning Cash (CF) $4.3B $3.1B $3.2B $3.3B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $860M -$2.2B $1.5B $375M $839M
Ending Cash (CF) $5.2B $904M $4.7B $3.6B $4.5B
 
Levered Free Cash Flow $2.7B $1.8B $1.8B $1.5B $1.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $6.5B $3.1B $3.3B $2.8B $2.5B
Depreciation & Amoritzation $785M $780M $850M $830M $824M
Stock-Based Compensation $330M $343M $438M $452M $522M
Change in Accounts Receivable -$105M $1.3B $278M -$929M -$524M
Change in Inventories -$2.2B $214M $668M -$852M -$828M
Cash From Operations $6.4B $4.5B $3.6B $3.7B $3.7B
 
Capital Expenditures $582M $791M $609M $592M $897M
Cash Acquisitions $854M $2.8B $7M $58M $116M
Cash From Investing -$1B -$3.5B -$590M -$646M -$1.2B
 
Dividends Paid (Ex Special Dividend) $938M $1B $1B $1.1B $1.1B
Special Dividend Paid
Long-Term Debt Issued $2.5B $4.2B $255M $380M --
Long-Term Debt Repaid -$1.2B -$1.1B -$1.7B -$213M --
Repurchase of Common Stock $6.2B $4.3B $100M $2.1B $850M
Other Financing Activities -- -- -$203M -- --
Cash From Financing -$6B -$2.1B -$2.9B -$3.1B -$2.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$565M -$1.2B $87M $21M $460M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $5.8B $3.7B $3B $3.2B $2.8B
Period Ending 2022-10-31 2023-10-31 2024-10-31 2025-10-31 2026-10-31
Net Income to Stockholders $3.1B $3.3B $2.8B $2.5B --
Depreciation & Amoritzation $780M $850M $830M $824M --
Stock-Based Compensation $343M $438M $452M $522M --
Change in Accounts Receivable $1.3B $278M -$929M -$524M --
Change in Inventories $214M $668M -$852M -$828M --
Cash From Operations $4.5B $3.6B $3.7B $3.7B --
 
Capital Expenditures $791M $609M $592M $897M --
Cash Acquisitions $2.8B $7M $58M $116M --
Cash From Investing -$3.5B -$590M -$646M -$1.2B --
 
Dividends Paid (Ex Special Dividend) $1B $1B $1.1B $1.1B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.2B $255M $380M $1.2B --
Long-Term Debt Repaid -$1.1B -$1.7B -$213M -$102M --
Repurchase of Common Stock $4.3B $100M $2.1B $850M --
Other Financing Activities $279M -$203M -- $6M --
Cash From Financing -$2.1B -$2.9B -$3.1B -$2.1B --
 
Beginning Cash (CF) $16.4B $8.7B $11.1B $12.2B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.2B $87M $21M $460M --
Ending Cash (CF) $15.2B $8.7B $11.1B $12.7B --
 
Levered Free Cash Flow $3.7B $3B $3.2B $2.8B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock